MR Anatomy of Deep Brain Nuclei with Special Reference to Specific Diseases and Deep Brain Stimulation Localization

Diseases affecting the basal ganglia and deep brain structures vary widely in etiology and include metabolic, infectious, ischemic, and neurodegenerative conditions. Some neurologic diseases, such as Wernicke encephalopathy or pseudohypoparathyroidism, require specific treatments, which if unrecognized could lead to further complications. Other pathologies, such as hypertrophic olivary degeneration, if not properly diagnosed may be mistaken for a primary medullary neoplasm and create unnecessary concern. The deep brain structures are complex and can be difficult to distinguish on routine imaging. It is imperative that radiologists first understand the intrinsic anatomic relationships between the different basal ganglia nuclei and deep brain structures with magnetic resonance (MR) imaging. It is important to understand the “normal” MR signal characteristics, locations, and appearances of these structures. This is essential to recognizing diseases affecting the basal ganglia and deep brain structures, especially since most of these diseases result in symmetrical, and therefore less noticeable, abnormalities. It is also crucial that neurosurgeons correctly identify the deep brain nuclei presurgically for positioning deep brain stimulator leads, the most important being the subthalamic nucleus for Parkinson syndromes and the thalamic ventral intermediate nucleus for essential tremor. Radiologists will be able to better assist clinicians in diagnosis and treatment once they are able to accurately localize specific deep brain structures.

[1]  D. Mikulis,et al.  Hypertrophic olivary degeneration: metaanalysis of the temporal evolution of MR findings. , 2000, AJNR. American journal of neuroradiology.

[2]  M. Lucic,et al.  MR imaging - an unreliable and potentially misleading diagnostic modality in patients with intracerebral calcium depositions. Case report. , 2009, Neuro endocrinology letters.

[3]  Chandrasekharan Kesavadas,et al.  Utility of susceptibility-weighted MRI in differentiating Parkinson’s disease and atypical parkinsonism , 2010, Neuroradiology.

[4]  M. van Buchem,et al.  Is There a Way to Predict Outcome in (Near) Term Neonates with Hypoxic-Ischemic Encephalopathy Based on MR Imaging? , 2008, American Journal of Neuroradiology.

[5]  Y. Mardor,et al.  Stereotactic Targeting of the Ventrointermediate Nucleus of the Thalamus by Direct Visualization with High-Field MRI , 2006, Stereotactic and Functional Neurosurgery.

[6]  D J Mikulis,et al.  Wallerian degeneration after cerebral infarction: evaluation with sequential MR imaging. , 1989, Radiology.

[7]  Francesco Fera,et al.  MR imaging index for differentiation of progressive supranuclear palsy from Parkinson disease and the Parkinson variant of multiple system atrophy. , 2008, Radiology.

[8]  D. Loewenstein,et al.  Medial temporal lobe atrophy on MRI scans and the diagnosis of Alzheimer disease , 2008, Neurology.

[9]  Clement Hamani,et al.  Novel applications of deep brain stimulation , 2012, Surgical neurology international.

[10]  À. Rovira,et al.  MR Imaging Findings in Hepatic Encephalopathy , 2008, American Journal of Neuroradiology.

[11]  Satoshi Takahashi,et al.  Symptomatic Characteristics of Parkinsonism and the Width of Substantia nigra pars compacta on MRI According to Ischemic Changes in the Putamen and Cerebral White Matter: Implications for the Diagnosis of Vascular Parkinsonism , 2001, European Neurology.

[12]  M. Castillo,et al.  Diffusion-weighted MR imaging of global cerebral anoxia. , 1999, AJNR. American journal of neuroradiology.

[13]  J. Mandrioli,et al.  Wernicke Encephalopathy: MR Findings at Clinical Presentation in Twenty-Six Alcoholic and Nonalcoholic Patients , 2007, American Journal of Neuroradiology.

[14]  S. Ashwal,et al.  Postoperative encephalopathy with choreoathetosis. , 2011, Handbook of clinical neurology.

[15]  Arpan Shrivastava The hot cross bun sign. , 2007, Radiology.

[16]  C. Tanner Epidemiology of Parkinson’s Disease , 1992, Neurologic Clinics.

[17]  Francis O. Walker Huntington's Disease. , 2007 .

[18]  V A Coenen,et al.  Localization of the Subthalamic Nucleus: Optimization with Susceptibility-Weighted Phase MR Imaging , 2009, American Journal of Neuroradiology.

[19]  Mario Mascalchi,et al.  Huntington disease: volumetric, diffusion-weighted, and magnetization transfer MR imaging of brain. , 2004, Radiology.

[20]  James W Ironside,et al.  Diagnosing variant Creutzfeldt-Jakob disease with the pulvinar sign: MR imaging findings in 86 neuropathologically confirmed cases. , 2003, AJNR. American journal of neuroradiology.

[21]  H. Urbach,et al.  Pattern of Cortical Changes in Sporadic Creutzfeldt-Jakob Disease , 2007, American Journal of Neuroradiology.

[22]  V. Virmani,et al.  The hot cross bun sign. , 2009, Neurology India.

[23]  A. Righini,et al.  MR imaging of the superior profile of the midbrain: differential diagnosis between progressive supranuclear palsy and Parkinson disease. , 2004, AJNR. American journal of neuroradiology.